跳至主要内容
临床试验/NCT03958396
NCT03958396已完成早期 1 期

The Pharmacokinetic and Pharmacodynamics Profiles of Remifentanil in Children With Obstructive Sleep Apnea.

Washington University School of Medicine0 个研究点目标入组 30 人开始时间: 2015年9月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
早期 1 期
状态
已完成
入组人数
30
主要终点
Change in respiratory rate from baseline over time - OSA Group

研究概览

简要总结

This investigation tested the hypothesis that children with obstructive sleep apnea have an increased pharmacodynamic sensitivity to the miotic and respiratory depressant effects of the prototypic μ-opioid agonist remifentanil.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
8 Years 至 14 Years(Child)
性别
All
接受健康志愿者

入选标准

  • 8-14 years old
  • ASA physical status 1 or 2
  • undergoing tonsillectomy or tonsillectomy and adenoidectomy for known obstructive sleep apnea

排除标准

  • Inability to cooperate with study requirements (IV placement, sitting quietly, wearing goggles, etc.)
  • Control (Non-OSA) Group:
  • Inclusion Criteria:
  • 8-14 years old
  • ASA physical status 1 or 2
  • no known obstructive sleep apnea presenting for any procedure requiring general anesthtic
  • Exclusion Criteria:
  • Inability to cooperate with study requirements (IV placement, sitting quietly, wearing goggles, etc.)

研究组 & 干预措施

OSA Group

Active Comparator

a) Children 8-14 years old, b) ASA physical status 1or 2, c) undergoing tonsillectomy or tonsillectomy and adenoidectomy for known obstructive sleep apnea

干预措施: Remifentanil Infusion (Drug)

Control (non-OSA) Group

Active Comparator

a) Children 8-14 years old, b) ASA physical status 1or 2, c) no known obstructive sleep apnea presenting for any procedure requiring general anesthetic

干预措施: Remifentanil Infusion (Drug)

结局指标

主要结局

Change in respiratory rate from baseline over time - OSA Group

时间窗: Approximately 1 hour before surgery - Measurements taken at 0, 1, 2, 4, 6, 10 & 15 minutes following remefentanil infusion

Respiratory monitoring was performed using nasal cannula

Change in pupil diameter from baseline over time - OSA Group

时间窗: Approximately 1 hour before surgery - Measured continuously and averaged into 10-s bins following remefentanil infusion

Dark adapted infrared pupillometry performed using binocular infrared pupilometer mounted in light occlusive goggles sampling at 100 Hz.

Change in pupil diameter from baseline over time - Control (non-OSA) Group

时间窗: Approximately 1 hour before surgery - Measured continuously and averaged into 10-s bins following remefentanil infusion

Dark adapted infrared pupillometry performed using binocular infrared pupilometer mounted in light occlusive goggles sampling at 100 Hz.

Change in end-expired carbon dioxide from baseline over time - OSA Group

时间窗: Approximately 1 hour before surgery - Measurements taken at 0, 1, 2, 4, 6, 10 & 15 minutes following remefentanil infusion

End-expired carbon dioxide monitoring using bedside monitoring

Change in end-expired carbon dioxide from baseline over time - Control (non-OSA) Group

时间窗: Approximately 1 hour before surgery - Measurements taken at 0, 1, 2, 4, 6, 10 & 15 minutes following remefentanil infusion

End-expired carbon dioxide monitoring using bedside monitoring

Change in respiratory rate from baseline over time - Control (non-OSA) Group

时间窗: Approximately 1 hour before surgery - Measurements taken at 0, 1, 2, 4, 6, 10 & 15 minutes following remefentanil infusion

Respiratory monitoring was performed using nasal cannula

Remifentanil plasma concentration - OSA Group

时间窗: Approximately 1 hour before surgery - Blood draws at 0, 1, 2, 4, 6, 10 & 15 minutes following remefentanil infusion

3ml blood draw

Remifentanil plasma concentration - Contro (non-OSA) Group

时间窗: Approximately 1 hour before surgery - Blood draws at 0, 1, 2, 4, 6, 10 & 15 minutes following remefentanil infusion

3ml blood draw

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

相似试验